Worth reading
29Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Reports on our company
Subject Entity
Sumitomo Pharma Co.,Ltd. and the Group
Occurrence3 August 2026 (the date Gotham City Research LLC published the report)
This disclosure08/04/2026
Cause
Gotham City Research LLC published a report based on its own views and assertions
Outlook
The Company will continue striving to make timely and appropriate disclosures.
| Item | Details |
|---|---|
| Event name | Reports on our company |
| Date of occurrence | 3 August 2026 (the date Gotham City Research LLC published the report) |
| Subject Entity | Sumitomo Pharma Co.,Ltd. and the Group |
| Cause | Gotham City Research LLC published a report based on its own views and assertions |
| Outlook | The Company will continue striving to make timely and appropriate disclosures. |
Items this document does not state (20)
Date recognized / date notice receivedTarget Locations / ProductsAmount of Impact on Business PerformanceAccounting period in which recognizedImpact on Earnings ForecastType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The report is based on the author's own views and assertions, while Sumitomo Pharma Co.,Ltd. prepares and discloses its financial statements and other disclosures in accordance with applicable laws and accounting standards and has received an unqualified audit opinion from its independent auditor.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.